Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Conditions: Pulmonary Embolism; Embolism; Embolism and Thrombosis; Lung Diseases; Cardiovascular Diseases; Respiratory Tract Diseases; Venous Thromboembolism; Anticoagulant-induced Bleeding; Bleeding Interventions: Drug: Rivaroxaban; Drug: Placebo Sponsors: University Hospital Inselspital, Berne; University of Bern; Schweizerischer Nationalfonds; Leiden University Medical Center; The Ottawa Hospital; Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bleeding | Cardiology | Heart | Hospitals | Pulmonary Thromboembolism | Research | Thrombosis